Diabetes mellitus is the commonest and fastest growing cause of end-stage renal disease in the developed world. Most ongoing laboratory and clinical research into the diabetic kidney focuses on injury and scarring that begin after 15-20 years of diabetes. However, the original idea that an early hemodynamic phenotype provokes the subsequent demise of a diabetic kidney continues to justify interest in the earlier stages of diabetes. Early diabetes is characterized by both glomerular hyper filtration and increased kidney size. Early diabetes also modifies the renal vascular response to a variety of physiologic stimuli including changes in perfusion pressure, salt intake, protein feeding, and exogenous insulin. While intrarenal hemodynamic abnormalities are potentially critical to the pathogenesis of diabetic nephropathy, the elemental cause of these abnormalities is poorly understood. It is the main purpose of this research to understand the cardinal renal hemodynamic abnormalities that occur at the start of diabetes, long before the onset of kidney damage. The foundation for this competing renewal rests on observations made during the last funding period. A central theme is that apparent abnormalities of glomerular function in early diabetes often represent a physiologic response of the glomerulus to primary abnormalities in the proximal tubule or loop of Henley that impact the glomerulus by feedback through the macula densa. Utilizing rats and mice with early streptozotocin diabetes, data will be obtained on nephron function by renal micropuncture, on functional genomics by laser capture micro dissection followed by quantitative RTPCR, and on protein expression by immunohistochemistry.
The Specific Aims are: 1) To answer key questions regarding factors that drive kidney growth in early diabetes, and 2) To answer key questions regarding peculiarities of tubular reabsorption and the functional interactions between the tubule and glomerulus that occur in early diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK056248-09
Application #
7390262
Study Section
Pathobiology of Kidney Disease Study Section (PBKD)
Program Officer
Rys-Sikora, Krystyna E
Project Start
1999-09-15
Project End
2010-03-31
Budget Start
2008-04-01
Budget End
2009-03-31
Support Year
9
Fiscal Year
2008
Total Cost
$315,322
Indirect Cost
Name
Veterans Medical Research Fdn/San Diego
Department
Type
DUNS #
933863508
City
San Diego
State
CA
Country
United States
Zip Code
92161
Thomson, Scott C; Vallon, Volker (2018) Renal Effects of Incretin-Based Diabetes Therapies: Pre-clinical Predictions and Clinical Trial Outcomes. Curr Diab Rep 18:28
Hallow, K Melissa; Gebremichael, Yeshitila; Helmlinger, Gabriel et al. (2017) Primary proximal tubule hyperreabsorption and impaired tubular transport counterregulation determine glomerular hyperfiltration in diabetes: a modeling analysis. Am J Physiol Renal Physiol 312:F819-F835
Vallon, Volker; Thomson, Scott C (2017) Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition. Diabetologia 60:215-225
Gallo, Linda A; Ward, Micheal S; Fotheringham, Amelia K et al. (2016) Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice. Sci Rep 6:26428
Layton, Anita T; Vallon, Volker; Edwards, Aurélie (2016) Predicted consequences of diabetes and SGLT inhibition on transport and oxygen consumption along a rat nephron. Am J Physiol Renal Physiol 310:F1269-83
Layton, Anita T; Vallon, Volker; Edwards, Aurélie (2016) A computational model for simulating solute transport and oxygen consumption along the nephrons. Am J Physiol Renal Physiol 311:F1378-F1390
Layton, Anita T; Laghmani, Kamel; Vallon, Volker et al. (2016) Solute transport and oxygen consumption along the nephrons: effects of Na+ transport inhibitors. Am J Physiol Renal Physiol 311:F1217-F1229
Song, Panai; Onishi, Akira; Koepsell, Hermann et al. (2016) Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus. Expert Opin Ther Targets 20:1109-25
Vallon, Volker (2016) Tubular Transport in Acute Kidney Injury: Relevance for Diagnosis, Prognosis and Intervention. Nephron 134:160-166
Novikov, Aleksandra; Vallon, Volker (2016) Sodium glucose cotransporter 2 inhibition in the diabetic kidney: an update. Curr Opin Nephrol Hypertens 25:50-8

Showing the most recent 10 out of 120 publications